Investing.com -- CVS Health (NYSE: CVS) will not include Gilead Sciences (NASDAQ: GILD )’ new HIV prevention drug Yeztugo in its commercial plans for the time being, despite the medication’s proven ...

Investing.com -- British stocks opened lower on Wednesday, while the pound held steady as U.K. inflation rose more than expected in July, with the broader European market also trading in the red. As ...

Investing.com -- Thousands of Airbus workers in Britain will go on strike for 10 days starting next month over pay demands, potentially disrupting aircraft wing production, Unite trade union announced ...

U.K. stocks were higher after the close on Wednesday, as gains in the Tobacco, Healthcare Equipment & Services and Food & Drug Retailers sectors led shares highe ...

Republican legislators, who have dominated Texas politics for over two decades, have undertaken a rare mid-decade ...

Investing.com -- Federal Reserve policymakers continued to echo a patient approach on further rate cuts as would take some ...

NEW YORK (Reuters) -Tech stocks led declines on Wall Street, with worries about AI spurring debates about its future. The ...

BRASILIA (Reuters) -The judge at the center of escalating tensions between Brazil and the United States told Reuters he is ...

Investing.com-- SoftBank Group Corp. (TYO: 9984) and Intel (NASDAQ: INTC) announced on Monday that the Japanese tech conglomerate agreed to buy $2 billion worth of stock in the beleaguered chipmaker ...

NEW YORK (Reuters) -Developers are on track to add 33 gigawatts of solar power in the U.S. this year, accounting for about ...

Investing.com -- Boston Dynamics and Toyota (NYSE: TM) Research Institute (TRI) have demonstrated a significant advancement ...

Cantor Equity Partners IV, Inc. (CEPF) priced its initial public offering of 40 million Class A ordinary shares at $10.00 per share, the company announced. The offering is expected to raise $400 ...